Catherine M. Engelbert - Net Worth and Insider Trading
Catherine M. Engelbert Net Worth
The estimated net worth of Catherine M. Engelbert is at least $567,754 dollars as of 2024-04-27. Catherine M. Engelbert is the Director of McDonald's Corp and owns about 2,079 shares of McDonald's Corp (MCD) stock worth over $567,754. Details can be seen in Catherine M. Engelbert's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Catherine M. Engelbert has not made any transactions after 2023-04-03 and currently still holds the listed stock(s).
Transaction Summary of Catherine M. Engelbert
Catherine M. Engelbert Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Catherine M. Engelbert owns 2 companies in total, including Royalty Pharma PLC (RPRX) , and McDonald's Corp (MCD) .
Click here to see the complete history of Catherine M. Engelbert’s form 4 insider trades.
Insider Ownership Summary of Catherine M. Engelbert
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RPRX | Royalty Pharma PLC | 2022-06-24 | director |
| MCD | McDonald's Corp | 2023-04-03 | director |
Catherine M. Engelbert Latest Holdings Summary
Catherine M. Engelbert currently owns a total of 1 stock. Catherine M. Engelbert owns 2,079 shares of McDonald's Corp (MCD) as of April 3, 2023, with a value of $567,754.
Latest Holdings of Catherine M. Engelbert
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MCD | McDonald's Corp | 2023-04-03 | 2,079 | 273.09 | 567,754 |
Holding Weightings of Catherine M. Engelbert
Catherine M. Engelbert Form 4 Trading Tracker
According to the SEC Form 4 filings, Catherine M. Engelbert has made a total of 2 transactions in McDonald's Corp (MCD) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in McDonald's Corp is the acquisition of 38 shares on April 3, 2023, which cost Catherine M. Engelbert around $10,679.
Insider Trading History of Catherine M. Engelbert
- 1
Catherine M. Engelbert Trading Performance
GuruFocus tracks the stock performance after each of Catherine M. Engelbert's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Catherine M. Engelbert is 0.85%. GuruFocus also compares Catherine M. Engelbert's trading performance to market benchmark return within the same time period. The performance of stocks bought by Catherine M. Engelbert within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Catherine M. Engelbert's insider trading performs compared to the benchmark.
Performance of Catherine M. Engelbert
Average Return
1.92%
Outperforming Transactions
50%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -5.45 | 0.85 | 0.44 | 1.92 | 12.26 | 10.76 |
| Relative Return to S&P 500(%) | 1.95 | -4.45 | -10.21 | -25.73 | -9.39 | 0.42 |
Catherine M. Engelbert Ownership Network
Ownership Network List of Catherine M. Engelbert
Ownership Network Relation of Catherine M. Engelbert
Catherine M. Engelbert Owned Company Details
What does Royalty Pharma PLC do?
Who are the key executives at Royalty Pharma PLC?
Catherine M. Engelbert is the director of Royalty Pharma PLC. Other key executives at Royalty Pharma PLC include 10 percent owner Avara Management Ltd , EVP & CFO Terrance P. Coyne , and director & CEO & Chairman of the Board Pablo G. Legorreta .
Royalty Pharma PLC (RPRX) Insider Trades Summary
Over the past 18 months, Catherine M. Engelbert made no insider transaction in Royalty Pharma PLC (RPRX). Other recent insider transactions involving Royalty Pharma PLC (RPRX) include a net sale of 420,000 shares made by George W. Lloyd , a net sale of 2,479,950 shares made by Rory B Riggs , and a net purchase of 600,000 shares made by Pablo G. Legorreta .
In summary, during the past 3 months, insiders sold 0 shares of Royalty Pharma PLC (RPRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 4,484,548 shares of Royalty Pharma PLC (RPRX) were sold and 600,000 shares were bought by its insiders, resulting in a net sale of 3,884,548 shares.
Royalty Pharma PLC (RPRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Royalty Pharma PLC Insider Transactions
Catherine M. Engelbert Mailing Address
Above is the net worth, insider trading, and ownership report for Catherine M. Engelbert. You might contact Catherine M. Engelbert via mailing address: 110 North Carpenter Street, Chicago Il 60607.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
